全文获取类型
收费全文 | 3366588篇 |
免费 | 272752篇 |
国内免费 | 6031篇 |
专业分类
耳鼻咽喉 | 48517篇 |
儿科学 | 107530篇 |
妇产科学 | 93029篇 |
基础医学 | 474911篇 |
口腔科学 | 99412篇 |
临床医学 | 306382篇 |
内科学 | 652386篇 |
皮肤病学 | 70337篇 |
神经病学 | 280608篇 |
特种医学 | 134293篇 |
外国民族医学 | 1247篇 |
外科学 | 506882篇 |
综合类 | 82906篇 |
现状与发展 | 4篇 |
一般理论 | 1426篇 |
预防医学 | 271849篇 |
眼科学 | 79727篇 |
药学 | 252250篇 |
6篇 | |
中国医学 | 6248篇 |
肿瘤学 | 175421篇 |
出版年
2018年 | 33601篇 |
2016年 | 28892篇 |
2015年 | 33032篇 |
2014年 | 46908篇 |
2013年 | 71738篇 |
2012年 | 96432篇 |
2011年 | 101995篇 |
2010年 | 60263篇 |
2009年 | 57527篇 |
2008年 | 97122篇 |
2007年 | 102869篇 |
2006年 | 104024篇 |
2005年 | 101165篇 |
2004年 | 98193篇 |
2003年 | 94518篇 |
2002年 | 93308篇 |
2001年 | 153519篇 |
2000年 | 158982篇 |
1999年 | 134981篇 |
1998年 | 39144篇 |
1997年 | 35489篇 |
1996年 | 34991篇 |
1995年 | 33936篇 |
1994年 | 31922篇 |
1993年 | 29858篇 |
1992年 | 109689篇 |
1991年 | 106063篇 |
1990年 | 102953篇 |
1989年 | 99465篇 |
1988年 | 92454篇 |
1987年 | 91215篇 |
1986年 | 86624篇 |
1985年 | 83054篇 |
1984年 | 63001篇 |
1983年 | 54074篇 |
1982年 | 32661篇 |
1981年 | 29177篇 |
1980年 | 27489篇 |
1979年 | 59838篇 |
1978年 | 42092篇 |
1977年 | 35521篇 |
1976年 | 33313篇 |
1975年 | 35267篇 |
1974年 | 43490篇 |
1973年 | 41540篇 |
1972年 | 38704篇 |
1971年 | 36030篇 |
1970年 | 33644篇 |
1969年 | 31418篇 |
1968年 | 28657篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
981.
Eisen G. M. Eliakim R. Zaman A. 《世界核心医学期刊文摘》2006,2(5):27-28
背景与研究目的:静脉曲张破裂出血是肝硬化的一个主要并发症,与6周内20%的死亡率有关。目前国际指南推荐肝硬化患应常规行上消化道内镜检查(食管胃十二指肠内镜检查,EGD)来筛查是否有食管静脉曲张。新近出现的食管胶囊内镜在对胃食管反流和Barrett食管的研究中已经显示出准确的诊断效应。该研究比较胶囊内镜和EGD对肝硬化患食管胃底静脉曲张和门脉高压性胃病的检出率。患与方法:在3个中心进行了先导试验。有进行EGD临床指征的肝硬化患,在EGD检查后48h内用胶囊内镜来筛查或监视食管静脉曲张。研究采用盲法,即由1名事先不知道患病史和EGD检查结果的研究评估胶囊视频成像。结果:在32例纳入的患中,EGD和胶囊内镜检查发现有食管静脉曲张23例患。有1例患经胶囊内镜发现有轻度静脉曲张,但EGD未检出。胶囊内镜和EGD诊断食管静脉曲张和门脉高压性胃病的总体一致性分别为96.9%和90.6%。没有与胶囊内镜相关的不良事件。 相似文献
982.
Zusammenfassung Dieser Artikel stellt eine Übersetzung der im Jahr 2006 herausgegebenen Empfehlungen zur Behandlung von Patienten mit spontaner intrazerebraler Blutung der Europäischen Schlaganfallinitiative (EUSI) für das Europäische Schlaganfall-Council (ESC), die Europäische Neurologische Gesellschaft (ENS) und die Europäische Förderation Neurologischer Gesellschaften (EFNS) dar.Diese EUSI-Empfehlungen werden von dem European Stroke Council (ESC), der European Neurological Society (ENS) und der European Federation of Neurological Societies (EFNS) unterstützt. 相似文献
983.
984.
OBJECTIVES: To pilot the acceptability and feasibility of clinical audit in free and pedicled flap reconstruction. To establish a baseline flap failure rate in participating units, so that a sample size calculation could be performed for future national audit. METHODS: A proforma was piloted over a 3-month period in four participating units, during which time data on 93 reconstructive procedures involving free and pedicled flaps was collected. The patients included those where large transfers of tissue were required such as for coverage of grade IIIb compound tibial fractures and breast reconstruction after mastectomy, and also smaller flap transfers such as after skin cancer excision. RESULTS: The proforma was found to be acceptable to clinicians and the feasibility of the data collection process was established. Overall there was a total flap survival of 89% and secondary operations to the donor or recipient sites were required in 11% of patients. CONCLUSIONS: This study demonstrates the feasibility of comparative audit for free and pedicled flap procedures using the methods proposed. Based on the incidence of flap failure observed in this pilot study, at least 18 months of prospective data collection on consecutive patients is required to fulfil the statistical requirements of comparative audit. The establishment of a routinely collected minimum dataset is proposed as one means of meeting these requirements. 相似文献
985.
Posttraumatic stress disorder and associated risk factors in Canadian peacekeeping veterans with health-related disabilities. 总被引:2,自引:0,他引:2
OBJECTIVES: This study investigates posttraumatic stress disorder (PTSD) and its associated risk factors in a random, national, Canadian sample of United Nations peacekeeping veterans with service-related disabilities. METHODS: Participants included 1016 male veterans (age < 65 years) who served in the Canadian Forces from 1990 to 1999 and were selected from a larger random sample of 1968 veterans who voluntarily and anonymously completed a general health survey conducted by Veterans Affairs Canada in 1999. Survey instruments included the PTSD Checklist-Military Version (PCL-M), Center for Epidemiological Studies-Depression Scale (CES-D), and questionnaires regarding life events during the past year, current stressors, sociodemographic characteristics, and military history. RESULTS: We found that rates of probable PTSD (PCL-M score > 50) among veterans were 10.92% for veterans deployed once and 14.84% for those deployed more than once. The rates of probable clinical depression (CES-D score > 16) were 30.35% for veterans deployed once and 32.62% for those deployed more than once. We found that, in multivariate analyses, probable PTSD rates and PTSD severity were associated with younger age, single marital status, and deployment frequency. CONCLUSIONS: PTSD is an important health concern in the veteran population. Understanding such risk factors as younger age and unmarried status can help predict morbidity among trauma-exposed veterans. 相似文献
986.
Social phobia, fear of negative evaluation and harm avoidance. 总被引:1,自引:0,他引:1
M Faytout J Tignol J Swendsen D Grabot B Aouizerate J P Lépine 《European psychiatry》2007,22(2):75-79
This naturalistic, prospective investigation examined the role of fear of negative evaluation and the personality trait of harm avoidance in the anxiety levels of treated social phobia patients. One hundred and fifty-seven patients with DSM-IV social phobia were assessed before starting treatment and were then followed for up to two years. As expected, greater fear of negative evaluation and higher scores of harm avoidance were associated with greater anxiety at the 6 month follow-up, and harm avoidance remained a significant predictor at 24 months. However, no evidence was found for an interaction between the personality and cognitive variables examined. The findings are discussed in terms of the relative independence of these factors, as well as their potential implications for the treatment of this disorder. 相似文献
987.
988.
989.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
990.
D Gröne† R Treudler† EM de Villiers‡ R Husak† CE Orfanos† ChC Zouboulis†§ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):202-205
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment. 相似文献